Clinical Evaluation of Ultrasonic Hydration Monitor for Infants (IHM-01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01482208
Recruitment Status : Completed
First Posted : November 30, 2011
Last Update Posted : March 31, 2014
Bill and Melinda Gates Foundation
Information provided by (Responsible Party):
Artann Laboratories

Brief Summary:
Study will verify ability of infant Hydration Monitor (IHM) to assess changes of hydration status in newborns and infants by means of ultrasound velocity measurements through muscle tissues. Changes of tissue hydration will be followed during first days of life in newborns and in acute diarrhea in small children during re-hydration therapy. Weighting and clinical dehydration symptoms will be used as controls.

Condition or disease
Diarrhea Dehydration

Study Type : Observational
Actual Enrollment : 42 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Study of Ultrasonic Hydration Monitor for Neonatology and Pediatric Children and Infants and/or Children up to Age 3 Years Old With Diarrhea
Study Start Date : November 2011
Actual Primary Completion Date : October 2012
Actual Study Completion Date : October 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Dehydration Diarrhea
U.S. FDA Resources

Primary Outcome Measures :
  1. Assess the ability of IHM to measure changes of hydration status ni newborn and infants [ Time Frame: 1 week to several months ]
    Infants and small children diagnosed with diarrhea or presenting to the hopsital with diseases known to cause dehydration are eligible

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   up to 3 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Newborns from 1 to 7 days Small children from 1 month to 3 years old

Inclusion Criteria:

  • Newborns from 1 to 7 days old,
  • Health infants from 1 month to 3 years old,
  • Any ethnicity,
  • Male or female,
  • Infants with diarrhea,
  • Acute gastroenteritis,
  • Diarrhea and/or vomiting,
  • Suspected dehydration

Exclusion Criteria:

  • Congenital heart disease,
  • Renal failure,
  • Chronic liver disease,
  • Chronic lung disease,
  • Inflammatory bowel disease,
  • Immune deficiency,
  • Severe malnutrition,
  • Any external damage to skin of leg,
  • Infants and Children whose parents refuse permission to be included

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01482208

Children Clinical University Hospital (CCUH) of the Riga Stradinsh University (RSU)
Riga, Latvia, LV-1004
Sponsors and Collaborators
Artann Laboratories
Bill and Melinda Gates Foundation
Principal Investigator: Dace Gardovska, Dr. Med. Head of Pediatrics, CCUH RSU

Additional Information:
Responsible Party: Artann Laboratories Identifier: NCT01482208     History of Changes
Other Study ID Numbers: IHM-01
Gates Foundation ( Other Identifier: Bill and Melinda Gates Foundation Round 6 )
First Posted: November 30, 2011    Key Record Dates
Last Update Posted: March 31, 2014
Last Verified: March 2014

Keywords provided by Artann Laboratories:
Muscle composition

Additional relevant MeSH terms:
Signs and Symptoms, Digestive
Signs and Symptoms
Water-Electrolyte Imbalance
Metabolic Diseases
Pathologic Processes